Erik Ames

1.2k citations

26 papers · 965 indexed · h-index 15

Impact in

Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis

Papers in ⓘ

Immunology 22
- Immune Cell Function and Interaction 18
- T-cell and B-cell Immunology 11
- Immunotherapy and Immune Responses 6
Hematology 6
- Hematopoietic Stem Cell Transplantation 5

Co-authors: William J. Murphy (21 shared papers)Mingyi Chen (8 shared papers)Steven K. Grossenbacher (8 shared papers)William Hallett (3 shared papers)Robert J. Canter (8 shared papers)Arta M. Monjazeb (7 shared papers)Thomas J. Sayers (3 shared papers)Isabel Barão (4 shared papers)
Journals: Blood (5 papers)The Journal of Immunology (4 papers)Biology of Blood and Marrow Transplantation (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
Partner nations: United States Australia Taiwan

In The Last Decade

Erik Ames

24 papers receiving 951 citations

Peers

Countries citing papers authored by Erik Ames

Since Specialization

Citations

This map shows the geographic impact of Erik Ames's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Ames with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Ames more than expected).

Fields of papers citing papers by Erik Ames

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Ames. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Ames. The network helps show where Erik Ames may publish in the future.

Co-authors

The 25 scholars most cited alongside Erik Ames, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erik Ames Line = papers co-authored together Erik Ames links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype The Journal of Immunology ·Erik Ames, Robert J. Canter, Steven K. Grossenbacher, Stephanie Mac, Mingyi Chen, Rachel Smith, Takeshi Hagino, Jessica Perez-Cunningham, Gail D. Sckisel, Shiro Urayama, Arta M. Monjazeb, Rubén Fragoso, Thomas J. Sayers, William J. Murphy	2015	181
2	Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition The Journal of Immunology ·William Hallett, Erik Ames, Milad Motarjemi, Isabel Barão, Anil Shanker, David Tamang, Thomas J. Sayers, Dorothy Hudig, William J. Murphy	2008	121
3	Out-of-Sequence Signal 3 Paralyzes Primary CD4+ T-Cell-Dependent Immunity Immunity ·Gail D. Sckisel, Myriam N. Bouchlaka, Arta M. Monjazeb, Marka R. Crittenden, Brendan D. Curti, Danice Wilkins, Kory A. Alderson, Can M. Sungur, Erik Ames, Annie Mirsoian, Abhinav Reddy, Warren S. Alexander, Athena M. Soulika, Bruce R. Blazar, Dan L. Longo, Robert H. Wiltrout, William J. Murphy	2015	88
4	Advantages and clinical applications of natural killer cells in cancer immunotherapy Cancer Immunology Immunotherapy ·Erik Ames, William J. Murphy	2013	78
5	Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy Blood ·Julia K. Tietze, Danice Wilkins, Gail D. Sckisel, Myriam N. Bouchlaka, Kory L. Alderson, Jonathan M. Weiss, Erik Ames, Kevin W. Bruhn, Noah Craft, Robert H. Wiltrout, Dan L. Longo, Lewis L. Lanier, Bruce R. Blazar, Doug Redelman, William J. Murphy	2012	76
6	Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells OncoImmunology ·Erik Ames, Robert J. Canter, Steven K. Grossenbacher, Stephanie Mac, Rachel Smith, Arta M. Monjazeb, Mingyi Chen, William J. Murphy	2015	63
7	Treatment of chronic graft-versus-host disease with bortezomib Blood ·Chien-Chun Steven Pai, Mingyi Chen, Annie Mirsoian, Steven K. Grossenbacher, Joseph Tellez, Erik Ames, Kai Sun, Jared Jagdeo, Bruce R. Blazar, William J. Murphy, Mehrdad Abedi	2014	53
8	Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC Blood ·Isabel Barão, Maite Álvarez, Erik Ames, Mark T. Orr, Heather E. Stefanski, Bruce R. Blazar, Lewis L. Lanier, Stephen K. Anderson, Doug Redelman, William J. Murphy	2011	41
9	Combination Therapy Using IL-2 and Anti-CD25 Results in Augmented Natural Killer Cell–Mediated Antitumor Responses Biology of Blood and Marrow Transplantation ·William Hallett, Erik Ames, Maite Álvarez, Isabel Barão, Patricia A. Taylor, Bruce R. Blazar, William J. Murphy	2008	41
10	Sensitization of human breast cancer cells to natural killer cell-mediated cytotoxicity by proteasome inhibition Clinical & Experimental Immunology ·Erik Ames, William Hallett, William J. Murphy	2009	37
11	Mouse NK cell–mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing Blood ·Kai Sun, Maite Álvarez, Erik Ames, Isabel Barão, Mingyi Chen, Dan L. Longo, Doug Redelman, William J. Murphy	2011	34
12	Murine natural killer cell licensing and regulation by T regulatory cells in viral responses Proceedings of the National Academy of Sciences ·Can M. Sungur, Yajarayma Tang-Feldman, Erik Ames, Maite Álvarez, Mingyi Chen, Dan L. Longo, Claire Pomeroy, William J. Murphy	2013	34
13	Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells Cancers ·Jesus I. Luna, Steven K. Grossenbacher, Ian R. Sturgill, Erik Ames, Sean J. Judge, Lyes A Bouzid, Morgan Darrow, William J. Murphy, Robert J. Canter	2019	21
14	Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma BMC Cancer ·Robert J. Canter, Erik Ames, Stephanie Mac, Steven K. Grossenbacher, Mingyi Chen, Chin-Shang Li, Dariusz Borys, Rachel Smith, Joe Tellez, Thomas J. Sayers, Arta M. Monjazeb, William J. Murphy	2014	20
15	Natural Killer Cell Subsets Differentially Reject Embryonic Stem Cells Based on Licensing Transplantation ·Jessica Perez-Cunningham, Erik Ames, Rachel Smith, Anna K. Peter, Ridhima Naidu, Jan A. Nolta, William J. Murphy	2014	16
16	Immune targeting of cancer stem cells in gastrointestinal oncology. PubMed ·Robert J. Canter, Steven K. Grossenbacher, Erik Ames, William J. Murphy	2016	13
17	IFN-γ Receptor-Deficient Donor T Cells Mediate Protection from Graft-versus-Host Disease and Preserve Graft-versus-Tumor Responses after Allogeneic Bone Marrow Transplantation The Journal of Immunology ·Kai Sun, Hui-Hua Hsiao, Minghui Li, Erik Ames, Myriam N. Bouchlaka, (unknown), Takeshi Hagino, Jared Jagdeo, Chien-Chun Steven Pai, Mingyi Chen, Bruce R. Blazar, Mehrdad Abedi, William J. Murphy	2012	13
18	Sclerosing mucoepidermoid carcinoma with eosinophilia: Cytologic characterization of a rare distinct entity in the thyroid Diagnostic Cytopathology ·Erik Ames, Michael J. Campbell, Alaa Afify, Jeffrey F. Krane, Eric C. Huang	2018	10
19	Contrasting Effects of Anti-Ly49A Due to MHC Class I cis Binding on NK Cell–Mediated Allogeneic Bone Marrow Cell Resistance The Journal of Immunology ·Maite Álvarez, Can M. Sungur, Erik Ames, Stephen K. Anderson, Claire Pomeroy, William J. Murphy	2013	7
20	Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment International review of cell and molecular biology ·Cordelia Dunai, Erik Ames, María C. Ochoa, Myriam Fernández-Sendin, Ignacio Melero, Federico Simonetta, Jeanette Baker, Maite Álvarez	2022	6

About Erik Ames

Erik Ames is a scholar working on Immunology, Hematology, Oncology, Biotechnology and Small Animals, having authored 26 papers that have together received 965 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (18 papers), T-cell and B-cell Immunology (11 papers), CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer Cells and Metastasis (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Cancer Research and Treatments (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Immunology (740 citations), Oncology (488 citations), Hematology (160 citations), Cancer Research (51 citations) and Genetics (31 citations). Erik Ames has collaborated with scholars based in United States, Australia and Taiwan. Frequent co-authors include William J. Murphy, Mingyi Chen, Steven K. Grossenbacher, William Hallett, Robert J. Canter, Arta M. Monjazeb, Thomas J. Sayers, Isabel Barão, Rachel Smith and Gail D. Sckisel. Their work appears in journals such as Blood, The Journal of Immunology, Biology of Blood and Marrow Transplantation, Journal for ImmunoTherapy of Cancer and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact